HUM logo

Humana Stock Price

Symbol: NYSE:HUMMarket Cap: US$37.3bCategory: Healthcare

HUM Share Price Performance

US$311.98
-59.42 (-16.00%)
10.4% undervalued intrinsic discount
US$348.00
Fair Value
US$311.98
-59.42 (-16.00%)
11.6% undervalued intrinsic discount
US$353.00
Fair Value
Price US$311.98
AnalystHighTarget US$353.00
AnalystConsensusTarget US$290.66
AnalystLowTarget US$250.00

HUM Community Narratives

AnalystHighTarget·Updated
Fair Value US$348.00 10.4% undervalued intrinsic discount

Aging Population And Tech Will Shape Long-Term Medicare Care

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·Updated
Fair Value US$291.82 6.9% overvalued intrinsic discount

AI, In-Home Visits, Medicaid And CenterWell Will Improve Care Delivery

0users have liked this narrative
0users have commented on this narrative
55users have followed this narrative
AnalystLowTarget·Updated
Fair Value US$224.00 39.3% overvalued intrinsic discount

Reforms And Rising Costs Will Erode Medicare Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent HUM News & Updates

Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

Aug 26
Humana (NYSE:HUM) Has Affirmed Its Dividend Of $0.885

Humana Inc. (NYSE:HUM) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Aug 15
Humana Inc. (NYSE:HUM) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Humana's Sharp Decline And Star Rating Troubles Lead Me To Stay Neutral For Now

Jul 22

Humana Inc. Key Details

US$123.1b

Revenue

US$104.6b

Cost of Revenue

US$18.5b

Gross Profit

US$16.9b

Other Expenses

US$1.6b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 05, 2025
Earnings per share (EPS)
13.10
Gross Margin
15.03%
Net Profit Margin
1.28%
Debt/Equity Ratio
70.6%

Humana Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet average dividend payer.

0 Risks
2 Rewards

About HUM

Founded
1961
Employees
65680
CEO
James Rechtin
WebsiteView website
www.humana.com

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Market Insight

The number of IPOs and the capital raised this year are on track to outpace the last three years combined. And the thing is, successful IPOs attract more IPOs. Some will be genuine gems, while others, not so much. That’s why this week, we’re digging into the IPO market, and more importantly, how you can improve your odds of spotting a winner.
Continue reading

U.S. Market Performance

  • 7 Days: -0.6%
  • 3 Months: 8.7%
  • 1 Year: 18.1%
  • Year to Date: 9.7%
The Communication Services sector gained 3.6% while the market remained flat over the last week. More promisingly, the market is up 18% over the past year. Earnings are forecast to grow by 15% annually. Market details ›